[HTML][HTML] Capsaicin: current understanding of its mechanisms and therapy of pain and other pre-clinical and clinical uses

V Fattori, MSN Hohmann, AC Rossaneis… - Molecules, 2016 - mdpi.com
In this review, we discuss the importance of capsaicin to the current understanding of
neuronal modulation of pain and explore the mechanisms of capsaicin-induced pain. We …

Postmenopausal hormone therapy: an Endocrine Society scientific statement

RJ Santen, DC Allred, SP Ardoin… - The Journal of …, 2010 - academic.oup.com
Objective: Our objective was to provide a scholarly review of the published literature on
menopausal hormonal therapy (MHT), make scientifically valid assessments of the available …

Efficacy and tolerability of mirabegron, a β3-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European–Australian phase 3 trial

V Khullar, G Amarenco, JC Angulo, J Cambronero… - European urology, 2013 - Elsevier
BACKGROUND: Mirabegron, a β3-adrenoceptor agonist, has been developed for the
treatment of overactive bladder (OAB). OBJECTIVE: To assess the efficacy and tolerability of …

Overactive bladder syndrome: evaluation and management

E Leron, AY Weintraub, SA Mastrolia, P Schwarzman - Current urology, 2018 - karger.com
Overactive bladder (OAB) syndrome is a chronic medical condition which has a major
influence on the quality of life in a significant amount of the population. OAB affects …

Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature

CC Sexton, SM Notte, C Maroulis… - … journal of clinical …, 2011 - Wiley Online Library
Overactive bladder syndrome (OAB) is a chronic condition that has an impact on patients'
daily activities and health‐related quality of life (HRQL). Anticholinergic therapy is often …

Neurogenic bladder

PT Dorsher, PM McIntosh - Advances in urology, 2012 - Wiley Online Library
Congenital anomalies such as meningomyelocele and diseases/damage of the central,
peripheral, or autonomic nervous systems may produce neurogenic bladder dysfunction …

Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score

Y Homma, H Kakizaki, O Yamaguchi, T Yamanishi… - Urology, 2011 - Elsevier
OBJECTIVES: To compare the Overactive Bladder Symptom Score (OABSS) and a bladder
diary as a tool for assessing symptoms of overactive bladder (OAB). METHODS: Treatment …

Results of a randomized, double‐blind, parallel‐group, placebo‐and active‐controlled, multicenter study of mirabegron, a β3‐adrenoceptor agonist, in patients with …

HC Kuo, KS Lee, Y Na, R Sood, S Nakaji… - Neurourology and …, 2015 - Wiley Online Library
Aims To assess the efficacy and safety of mirabegron 50 mg once daily compared with
placebo and the active control, tolterodine extended‐release (ER) 4 mg once daily, in …

Solifenacin as add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms—ASSIST, randomized controlled study

O Yamaguchi, H Kakizaki, Y Homma, M Takeda… - Urology, 2011 - Elsevier
Objectives To assess the efficacy and safety of solifenacin add-on therapy to tamsulosin in
lower urinary tract symptoms (LUTS) men with residual overactive bladder (OAB) symptoms …

Outline of JUA clinical guidelines for benign prostatic hyperplasia

Y Homma, M Gotoh, O Yokoyama… - … Journal of Urology, 2011 - Wiley Online Library
Abstract The Japanese Urological Association has developed Clinical Guidelines for Benign
Prostatic Hyperplasia (BPH) for men with suspected BPH, which have been abridged and …